Nuveen International Equity Index Fund I Class (TCIHX)
| Fund Assets | 30.54B |
| Expense Ratio | 0.18% |
| Min. Investment | $1,000,000 |
| Turnover | 4.00% |
| Dividend (ttm) | 0.66 |
| Dividend Yield | 2.51% |
| Dividend Growth | 2.43% |
| Payout Frequency | Annual |
| Ex-Dividend Date | Dec 6, 2024 |
| Previous Close | 26.44 |
| YTD Return | 20.41% |
| 1-Year Return | 17.83% |
| 5-Year Return | 69.68% |
| 52-Week Low | 21.31 |
| 52-Week High | 26.53 |
| Beta (5Y) | n/a |
| Holdings | 711 |
| Inception Date | Dec 4, 2015 |
About TCIHX
Nuveen International Equity Index Fund I is an institutional mutual fund designed to deliver long-term total return through capital appreciation by investing primarily in foreign equity securities. The fund seeks to closely track the performance of the MSCI EAFE Index, a widely recognized benchmark representing large- and mid-cap companies across developed markets outside the United States and Canada. It typically allocates at least 80% of its assets to the equity securities within this index, using a sampling approach to match the overall characteristics of the benchmark. This fund offers exposure to a diverse mix of sectors, including healthcare, technology, consumer goods, and energy, with notable holdings in companies such as Novo Nordisk, ASML Holding, and Nestle. It emphasizes cost efficiency, maintaining a low expense ratio and turnover, making it competitive among its foreign large blend peers. With a global reach spanning at least three countries outside the U.S., the fund serves as a core international equity holding for institutional investors seeking diversified access to developed international markets while aiming to minimize tracking error and expenses.
Performance
TCIHX had a total return of 17.83% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.90%.
Top 10 Holdings
13.37% of assets| Name | Symbol | Weight |
|---|---|---|
| SAP SE | SAP | 1.69% |
| ICE US mini MSCI EAFE Index Futures | MFSM5 | 1.57% |
| Nestlé S.A. | NESN | 1.54% |
| ASML Holding N.V. | ASML | 1.46% |
| Roche Holding AG | ROG | 1.27% |
| Novartis AG | NOVN | 1.24% |
| AstraZeneca PLC | AZN | 1.23% |
| Novo Nordisk A/S - Novo Nordisk A.S. | n/a | 1.19% |
| HSBC Holdings plc | HSBA | 1.10% |
| Shell plc | SHEL | 1.09% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 6, 2024 | $0.66265 | Dec 9, 2024 |
| Dec 8, 2023 | $0.64696 | Dec 8, 2023 |
| Dec 9, 2022 | $0.51524 | Dec 9, 2022 |
| Dec 10, 2021 | $0.66589 | Dec 10, 2021 |
| Dec 11, 2020 | $0.39561 | Dec 11, 2020 |
| Dec 6, 2019 | $0.59997 | Dec 6, 2019 |